Literature DB >> 1313111

Susceptibility of selected strains of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) to chikungunya virus.

M J Turell1, J R Beaman, R F Tammariello.   

Abstract

The relative susceptibility of selected strains of Aedes aegypti (L.) and Aedes albopictus (Skuse) fed on a viremic monkey to infection with chikungunya virus was determined. Infection rates were consistently higher in 10 strains of Ae. albopictus tested than in 7 strains of Ae. aegypti tested, regardless of the geographic location from which the strains originated or the dose of virus ingested. Similarly, virus dissemination rates were higher in the Ae. albopictus strains compared with the Ae. aegypti strains. For nearly all (11 of 12) strains tested of both species, groups of mosquitoes with one or more females with a disseminated infection transmitted virus by bite to weanling mice. Based on these studies, Ae. albopictus appears to be a more competent laboratory vector of chikungunya virus than does Ae. aegypti.

Entities:  

Mesh:

Year:  1992        PMID: 1313111     DOI: 10.1093/jmedent/29.1.49

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  36 in total

Review 1.  Genetic variation in arthropod vectors of disease-causing organisms: obstacles and opportunities.

Authors:  R H Gooding
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

2.  Vector competence of Florida mosquitoes for chikungunya virus.

Authors:  Stephanie L Richards; Sheri L Anderson; Chelsea T Smartt
Journal:  J Vector Ecol       Date:  2010-12       Impact factor: 1.671

3.  High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus.

Authors:  Anubis Vega-Rúa; Karima Zouache; Romain Girod; Anna-Bella Failloux; Ricardo Lourenço-de-Oliveira
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis.

Authors:  Danher Wang; Andreas Suhrbier; Adam Penn-Nicholson; Jan Woraratanadharm; Joy Gardner; Min Luo; Thuy T Le; Itaru Anraku; Michael Sakalian; David Einfeld; John Y Dong
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

5.  Comparing dengue and chikungunya emergence and endemic transmission in A. aegypti and A. albopictus.

Authors:  Carrie A Manore; Kyle S Hickmann; Sen Xu; Helen J Wearing; James M Hyman
Journal:  J Theor Biol       Date:  2014-05-04       Impact factor: 2.691

Review 6.  Chikungunya: a potentially emerging epidemic?

Authors:  Michelle M Thiboutot; Senthil Kannan; Omkar U Kawalekar; Devon J Shedlock; Amir S Khan; Gopalsamy Sarangan; Padma Srikanth; David B Weiner; Karuppiah Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

7.  Effects of infectious virus dose and bloodmeal delivery method on susceptibility of Aedes aegypti and Aedes albopictus to chikungunya virus.

Authors:  Kendra Pesko; Catherine J Westbrook; Christopher N Mores; L Philip Lounibos; Michael H Reiskind
Journal:  J Med Entomol       Date:  2009-03       Impact factor: 2.278

8.  Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

Authors:  Karuppiah Muthumani; Katthikbabu M Lankaraman; Dominick J Laddy; Senthil G Sundaram; Christopher W Chung; Eric Sako; Ling Wu; Amir Khan; Niranjan Sardesai; Joseph J Kim; Paluru Vijayachari; David B Weiner
Journal:  Vaccine       Date:  2008-04-14       Impact factor: 3.641

9.  Susceptibility of Florida mosquitoes to infection with chikungunya virus.

Authors:  Michael H Reiskind; Kendra Pesko; Catherine J Westbrook; Christopher N Mores
Journal:  Am J Trop Med Hyg       Date:  2008-03       Impact factor: 2.345

10.  Chikungunya virus in US travelers returning from India, 2006.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Amanda J Panella; Jason O Velez; Amy J Lambert; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.